Showing results (271-280 of 686) with videos related to

Sort By:
Pageof 69
FEBS Letters|May 10, 2000
The Krüppel-like transcriptional factors Zf9 and GKLF coactivate the human keratin 4 promoter and physically interactJ Okano, O G Opitz, H Nakagawa, et al.
Neoplasia (New York, N.Y.)|April 5, 2013
ERK2-regulated TIMP1 induces hyperproliferation of K-Ras(G12D)-transformed pancreatic ductal cellsGregory P Botta, Maximilian Reichert, Mauricio J Reginato, et al.
Annals of Gastroenterology|July 19, 2021
Timing of endoscopic retrograde cholangiopancreatography in acute biliary pancreatitis without cholangitis: a nationwide inpatient cohort studySavan Kabaria, Hemant Mutneja, Michael Makar, et al.
Epilepsy & Behavior : E&B|February 24, 2021
Drug-induced liver injury associated with antiseizure medications from the FDA Adverse Event Reporting System (FAERS)Brad K Kamitaki, Carlos D Minacapelli, Pengfei Zhang, et al.
Gastro Hep Advances|August 12, 2024
The Role of Race, Sex, and Age in Circadian Disruption and Metabolic DisordersClark Zhang, Christopher Tait, Carlos D Minacapelli, et al.
Genes|November 25, 2023
Development of High-Yielding Upland Cotton Genotypes with Reduced Regrowth after Defoliation Using a Combination of Molecular and Conventional ApproachesSalman Naveed, Johnson Toyinbo, Hrishikesh Ingole, et al.
Cureus|October 9, 2023
Demographics and Outcomes Related to Wilson's Disease Patients: A Nationwide Inpatient Cohort StudyAnkoor H Patel, Meghana Ghattu, Natale Mazzaferro, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 31, 2002
Role of gender and race mismatch and graft failure in patients undergoing liver transplantationVinod K Rustgi, Gustavo Marino, Michael T Halpern, et al.
Science Advances|December 5, 2020
Growth of pancreatic cancers with hemizygous chromosomal 17p loss of MYBBP1A can be preferentially targeted by PARP inhibitorsAntony Hsieh, Jason R Pitarresi, Jonathan Lerner, et al.
Cancer Research|January 4, 1998
A transgenic mouse model with cyclin D1 overexpression results in cell cycle, epidermal growth factor receptor, and p53 abnormalitiesA Mueller, R Odze, T D Jenkins, et al.
Pageof 69